top of page

Tirzepatide (Mounjaro)

Tirzepatide works by activating the GIP and GLP-1 receptors, which can result in reduced appetite, increased feelings of fullness, slowed stomach emptying, and improved blood sugar control. Another common name for Tirzepatide is Mounjaro. 

​

Using Tirzepatide (Mounjaro) resulted in a weight loss of 17.8% compared with 12.4% for semaglutide (Ozempic) - National Library of Medicine (NIH), 2023

Injection based weight-loss with Tirzepatide

Tirzepatide affects appetite regulation, insulin sensitivity, and energy expenditure, which collectively contribute to weight loss:

​

  1. Weight Loss: Tirzepatide is being studied for its significant potential to induce weight loss. Clinical trials have shown that it can lead to substantial reductions in body weight for individuals with type 2 diabetes and obesity.

  2. Cardiovascular Benefits: In addition to its effects on weight and blood sugar, tirzepatide has shown potential cardiovascular benefits in clinical trials. It might have a positive impact on cardiovascular risk factors.

  3. Reduced Insulin Resistance: Tirzepatide's mechanism of action involves improving insulin sensitivity. This could be beneficial for individuals with insulin resistance, which is common in type 2 diabetes and obesity.

  4. Improved Blood Pressure: Some studies have suggested that tirzepatide might lead to improvements in blood pressure levels, which is important for cardiovascular health.

  5. Potential for Combination Therapy: Tirzepatide offers a new option for combination therapy in individuals who require both blood sugar management and weight loss.

  6. Once-Weekly Dosage: The convenience of a once-weekly dosing regimen might improve adherence to treatment compared to medications that need to be taken more frequently.

​

You may find further information about Tirzepatide by following this link: Tirzepatide Article

bottom of page